GOOG
42
-9
PFG
25
-8
AMG
49
-6
PNC
53
-2
VZ
45
-5
VMC
56
-3
NWS
66
-7
ADM
36
2
TSN
48
-2
ROK
23
-3
LH
42
9
ADSK
47
-2
ACN
18
-2
STT
48
-2
CMS
48
-2
MTB
50
-2
MSI
50
-8
LUV
40
-2
BEN
14
-5
ZTS
12
-2
GOOG
42
-9
PFG
25
-8
AMG
49
-6
PNC
53
-2
VZ
45
-5
VMC
56
-3
NWS
66
-7
ADM
36
2
TSN
48
-2
ROK
23
-3
LH
42
9
ADSK
47
-2
ACN
18
-2
STT
48
-2
CMS
48
-2
MTB
50
-2
MSI
50
-8
LUV
40
-2
BEN
14
-5
ZTS
12
-2
Financhill
Back

Genmab AS Stock Predictions

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
49

GMAB
Genmab AS

Last Price:
$20.03
Seasonality Move:
11.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Mode Mobile Could be Next in Line

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 25.3% based on the past 12 years of stock performance.
  • Genmab AS has risen higher in 9 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $19.55. The Score for GMAB is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 25.3% based on the past 12 years of stock performance.

Genmab AS Stock Rating

Sell
49
Genmab AS (GMAB) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 9 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • The current trend is relatively stagnant and GMAB is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
30.41
52-Week Low:
17.24

Prediction Charts

Market Cap:
12.4B
Price in USD:
19.55
Volume:
940.3K
Beta:
0.71

Technical Analysis

SMA50:
20.43
SMA100:
20.68
SMA200:
23.02
52-Wk Change:
-33.57%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 19.55 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-28 19.81 19.90 19.96 19.73
Mar-31 19.53 19.58 19.66 19.36
Apr-1 19.09 18.66 19.10 18.62
Apr-2 18.48 18.82 18.85 18.48
Apr-3 19.19 19.24 19.32 19.00
Apr-4 18.80 18.39 18.89 18.30
Apr-7 18.02 18.19 18.68 17.82
Apr-8 18.89 17.98 18.92 17.77
Apr-9 17.69 18.83 18.97 17.24
Apr-10 18.68 18.01 18.70 17.58
Apr-11 18.64 18.81 18.88 18.44
Apr-14 19.20 19.32 19.37 19.07
Apr-15 19.65 19.51 19.69 19.35
Apr-16 19.55 19.55 19.74 19.42

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $5.15 per share, an increase this year of $0.17 per share, and an increase next year of $0.31 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.